Siemens Healthineers
SMMNY · OTC · Healthcare
$21.69
$0.37 (-1.72%) today
Market Cap
$48.55B
24h Volume
$42.8K
P/E Ratio
19.0
52w High
$28.74
52w Low
$19.32
Est. AI Revenue
22%
7-Day Sparkline (Static)
Company facts
Performance
About Siemens Healthineers
Siemens Healthineers is a medical technology company. It sells imaging scanners, radiation therapy systems, and laboratory diagnostics equipment to hospitals and health systems, earning revenue from equipment sales, consumables, and services.
AI is embedded across that equipment: AI-Rad Companion assists radiologists with image interpretation, syngo.via applies AI to radiology workflows, Varian systems use AI for radiation therapy treatment planning, and Atellica brings AI to lab diagnostics.
The company traces its founding to 1847 and is headquartered in Erlangen, Germany. It employs about 74,300 people under CEO Bernd Montag, and its shares trade on US OTC markets.
Siemens Healthineers in the AI buildout
Siemens Healthineers sits in the AI Healthcare layer of the buildout as an equipment maker that embeds AI into clinical workflows. AI-Rad Companion and AI treatment planning differentiate its scanners and radiotherapy systems, helping hospitals read images and plan treatment faster. But its revenue is driven by hospital capital spending cycles rather than AI demand itself, so AI is a competitive edge on established products. Supercycle scores its AI exposure at 22 out of 100.
SMMNY is tracked in AI Healthcare, rated Peripheral on the AI Exposure leaderboard.
By the numbers
52-week range
SMMNY trades at $21.69, 25% of the way up its 52-week range of $19.32 to $28.74.
Market cap
Market capitalization is $48.55B, with an AI Exposure Score of 22 out of 100.
Valuation vs peers
Its P/E ratio of 19.0 is below the AI Healthcare category median of 29.6.
Next earnings
Siemens Healthineers is next expected to report earnings on November 5, 2026.
Market data as of the close on . Prices are end of day, not live.
Frequently asked questions
What does Siemens Healthineers do?
Siemens Healthineers sells medical imaging scanners, radiation therapy systems, and laboratory diagnostics to hospitals worldwide, earning revenue from equipment, consumables, and services.
How is Siemens Healthineers exposed to AI?
AI is embedded in its imaging, radiotherapy planning, and lab diagnostics products, differentiating the equipment. Revenue follows hospital capital spending, so Supercycle scores its AI exposure at 22 out of 100.
What are Siemens Healthineers' main AI products?
AI-Rad Companion for radiology assistance, syngo.via AI radiology workflows, Varian AI treatment planning for radiation therapy, and Atellica AI lab diagnostics.
Who leads Siemens Healthineers and where is it based?
CEO Bernd Montag leads the company from Erlangen, Germany. It traces its founding to 1847, employs about 74,300 people, and its shares trade on US OTC markets.
Is SMMNY a pure play AI stock?
No. Siemens Healthineers is a medical equipment maker that uses AI to differentiate its products. Its Supercycle AI Exposure Score is 22 out of 100.
Profile written 2026-08, updated as the business changes. Editorial content, not investment advice.